Recombinant Anti-EGFRvIII × Anti-CD3 Bispecific Antibody (Tandem Diabody) (CAT#: TAND-LC014)
The anti-EGFRvIII/CD3 antibody is a Tandem Diabody which specifically targeting both EGFRvIII and CD3. By recruiting T cell and killing tumor cells, the tandem daibody can be potentially used in the treatment of solid tumor.
Specific Inquiry
Specifications
- Target
- EGFRvIII & CD3
- Type
- Tandem Diabody
- Species Reactivity
- Human
- Target 1
- EGFRvIII
- Host Species 1
- Human
- Target 2
- CD3
- Host Species 2
- Human
- Application
- FuncS, Promising therapeutic agent
- Related Disease
- Prostate cancer, Non-small-cell-lung cancer, Breast cancer
Target
- Target 1
- EGFRvIII
- Alternative Names
- EGFRvIII; epidermal growth factor receptor variant III
- Target 2
- CD3
- Alternative Names
- CD3; CD3 T-Cell Co-receptor;CD3D; CD3E; CD3G
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAND-LC014. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.